Company Filing History:
Years Active: 2010-2012
Title: Clarissa Berlioz-Torrent: Innovator in HIV Research
Introduction
Clarissa Berlioz-Torrent is a prominent inventor based in Paris, France. She has made significant contributions to the field of HIV research, particularly in understanding protein-protein interactions involved in AIDS. With a total of 2 patents, her work has the potential to influence drug development and therapeutic strategies.
Latest Patents
Berlioz-Torrent's latest patents focus on critical aspects of HIV research. One patent addresses the interactions between human immunodeficiency virus integrase and transportin, as well as SR protein interactions. This invention relates to complexes of polypeptides or polynucleotides encoding these polypeptides, fragments of the polypeptides, and antibodies to the complexes. It also includes Selected Interacting Domains (SID®) identified through these interactions, methods for screening drugs that modulate these interactions, and pharmaceutical compositions capable of influencing protein-protein interactions. Another patent explores the interactions between human immunodeficiency virus integrase and the LEDGF p75 isoform, emphasizing similar themes of protein-protein interactions and their implications for AIDS research.
Career Highlights
Throughout her career, Clarissa Berlioz-Torrent has worked with notable companies such as Cellvir and Laboratoire Biodim. Her experience in these organizations has allowed her to develop her expertise in the field of HIV research and contribute to innovative solutions.
Collaborations
Berlioz-Torrent has collaborated with esteemed colleagues, including Pierre Legrain and Jean-Christophe Rain. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Clarissa Berlioz-Torrent is a trailblazer in the field of HIV research, with her patents paving the way for advancements in understanding and treating AIDS. Her contributions highlight the importance of innovation in addressing global health challenges.